Nimodipine

Basic Information

Item Value
DrugBank ID DB00393
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 41

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 homozygous familial hypercholesterolemia KG + DL
2 nephrogenic syndrome of inappropriate antidiuresis KG + DL
3 congestive heart failure KG + DL
4 acute pulmonary heart disease KG + DL
5 benign prostatic hyperplasia (disease) KG + DL
6 hyperlipoproteinemia KG + DL
7 hypertrichosis (disease) KG + DL
8 IRVAN syndrome KG + DL
9 Moyomoya angiopathy KG + DL
10 idiopathic macular telangiectasia KG + DL
11 vasoproliferative tumor of retina KG + DL
12 familial periodic paralysis KG + DL
13 primary hereditary glaucoma KG + DL
14 Ambras type hypertrichosis universalis congenita KG + DL
15 malformation syndrome with odontal and/or periodontal component KG + DL
16 open-angle glaucoma KG + DL
17 obsolete familial combined hyperlipidemia KG + DL
18 syndrome with a Dandy-Walker malformation as major feature KG + DL
19 benign choroid plexus neoplasm KG + DL
20 hypokalemic periodic paralysis KG + DL
21 malignant hyperthermia, susceptibility to KG + DL
22 isolated genetic hair shaft abnormality KG + DL
23 cerebral visual impairment KG + DL
24 common cold KG + DL
25 familial hypercholesterolemia KG + DL
26 exercise-induced malignant hyperthermia KG + DL
27 thyrotoxic periodic paralysis, susceptibility to KG + DL
28 King-Denborough syndrome KG + DL
29 cholesterol-ester transfer protein deficiency KG + DL
30 X-linked centronuclear myopathy KG + DL
31 hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency KG + DL
32 congenital multicore myopathy with external ophthalmoplegia KG + DL
33 central core myopathy KG + DL
34 periodic paralysis (disease) KG + DL
35 malignant hyperthermia of anesthesia KG + DL
36 prostate calculus KG + DL
37 moderate multiminicore disease with hand involvement KG + DL
38 thyrotoxic periodic paralysis KG + DL
39 Jeune syndrome KG + DL
40 hypotrichosis simplex of the scalp KG + DL
41 hyperlipidemia due to hepatic triglyceride lipase deficiency KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.